Tina Yi Jin Hsieh

observational 2026

GLP-1 Receptor Agonists Plus Progestins and Endometrial Cancer Risk in Nonmalignant Uterine Diseases

JAMA network open ·doi:10.1001/jamanetworkopen.2025.58205

IMPORTANCE: As endometrial cancer (EC) incidence rises, particularly among individuals with obesity and metabolic disorders, effective strategies targeting hormonal and metabolic risks are needed. OBJECTIVE: To evaluate EC risk in patients…

2025

Effects of glucagon-like peptide-1 receptor agonists on incident gynecologic cancer outcomes in endometriosis patients compared to metformin: A real-world multicenter retrospective cohort study across the United States

·doi:10.1016/j.ygyno.2025.04.222

2024

ASSOCIATIONS BETWEEN ENDOMETRIOSIS AND RISK OF COGNITIVE DISORDERS

·doi:10.1016/j.fertnstert.2024.08.198

2024

ASSOCIATIONS BETWEEN PRE-PREGNANCY ENDOMETRIOSIS AND POSTPARTUM PSYCHIATRIC DISORDERS

·doi:10.1016/j.fertnstert.2024.07.129